Reticulated hyaluronan hydrogels: A model for examining cancer cell invasion in 3D

Matrix Biology

Volumn 23, Issue 3, 2004, Pages 183-193

  David, Laurent ^a   Dulong, Virginie ^a   Le Cerf, Didier ^a   Chauzy, Claude ^a   Norris, Vic ^a   Delpech, Bertrand ^a   Lamacz, Marek ^a   Vannier, Jean Pierre ^a  

^a UNIVERSITÉ DE ROUEN   (France)

Author keywords

Cancer cell; Hyaluronan hydrogel; Tumor

Indexed keywords

HYALURONIC ACID;

ANIMAL CELL; ARTICLE; BINDING SITE; CANCER CELL; CANCER INVASION; CARCINOGENESIS; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; EXPERIMENTAL MODEL; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HYDROGEL; METASTASIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION;

BINDING SITES; BIOCOMPATIBLE MATERIALS; CELL LINE, TUMOR; CELL MOVEMENT; HEPARIN; HUMANS; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; HYDROGEL; NEOPLASM INVASIVENESS; NEOPLASMS; NEURAMINIDASE;

EID: 3843084007     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.matbio.2004.05.005     Document Type: Article

References (42)

1. Auvinen P., Tammi R., Parkkinen J., Tammi M., Agren U., Johansson R., et al. Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. Am. J. Pathol. 156:2000;529-536
2. Bohm J.P., Niskanen L.K., Pirinen R.T., Kiraly K., Kellokoski J.K., Moisio K.I., et al. Reduced CD44 standard expression is associated with tumour recurrence and unfavourable outcome in differentiated thyroid carcinoma. J. Pathol. 192:2000;321-327
3. Camenisch T.D., Spicer A.P., Brehm-Gibson T., Biesterfeldt J., Augustine M.L., Calabro A. Jr, et al. Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J. Clin. Invest. 106:2000;349-360
4. Cichy J., Pure E. Oncostatin M and transforming growth factor-beta 1 induce post-translational modification and hyaluronan binding to CD44 in lung- derived epithelial tumor cells. J. Biol. Chem. 275:2000;18 061-18 069
5. Corti C., Pratesi G., DeCesare M., Pellegrini R., Giardini R., Supino R., et al. Spontaneous lung metastases in a human lung tumor xenograft: a new experimental model. J. Cancer Res. Clin. Oncol. 122:1996;154-160
6. Csoka A.B., Frost G.I., Stern R. The six hyaluronidase-like genes in the human and mouse genomes. Matrix Biol. 20:2001;499-508
7. Delpech B., Bertrand P., Maingonnat C., Girard N., Chauzy C. Enzyme-linked hyaluronectin: a unique reagent for hyaluronan assay and tissue location and for hyaluronidase activity detection. Anal. Biochem. 229:1995;35-41
8. Delpech B., Girard N., Bertrand P., Courel M.N., Chauzy C., Delpech A. Hyaluronan: fundamental principles and applications in cancer. J. Intern. Med. 242:1997a;41-48
9. Delpech B., Girard N., Olivier A., Maingonnat C., van Driessche G., van Beeumen J., et al. The origin of hyaluronectin in human tumors. Int. J. Cancer. 72:1997b;942-948
10. Delpech B., Courel M.N., Maingonnat C., Chauzy C., Sesboue R., Pratesi G. Hyaluronan digestion and synthesis in an experimental model of metastatic tumour. Histochem. J. 33:2001;553-558
11. Delpech B., Laquerriere A., Maingonnat C., Bertrand P., Freger P. Hyaluronidase is more elevated in human brain metastases than in primary brain tumours. Anticancer Res. 22:2002;2423-2427
12. Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer. 2:2002;161-174
13. Gioanni J., Le Francois D., Zanghellini E., Mazeau C., Ettore F., Lambert J.C., et al. Establishment and characterisation of a new tumorigenic cell line with a normal karyotype derived from a human breast adenocarcinoma. Br. J. Cancer. 62:1990;8-13
14. Goodison S., Urquidi V., Tarin D. CD44 cell adhesion molecules. Mol. Pathol. 52:1999;189-196
15. Gross N., Balmas K., Beretta Brognara C. Role of CD44H carbohydrate structure in neuroblastoma adhesive properties. Med. Pediatr. Oncol. 36:2001;139-141
16. Hautmann S.H., Lokeshwar V.B., Schroeder G.L., Civantos F., Duncan R.C., Gnann R., et al. Elevated tissue expression of hyaluronic acid and hyaluronidase validates the HA-HAase urine test for bladder cancer. J. Urol. 165:2001;2068-2074
17. Jacobson A., Rahmanian M., Rubin K., Heldin P. Expression of hyaluronan synthase 2 or hyaluronidase 1 differentially affect the growth rate of transplantable colon carcinoma cell tumors. Int. J. Cancer. 102:2002;212-219
18. Kincade P.W., Zheng Z., Katoh S., Hanson L. The importance of cellular environment to function of the CD44 matrix receptor. Curr. Opin. Cell. Biol. 9:1997;635-642
19. Knudson W., Chow G., Knudson C.B. CD44-mediated uptake and degradation of hyaluronan. Matrix Biol. 21:2002;15-23
20. Lee J.Y., Spicer A.P. Hyaluronan: a multifunctional, megaDalton, stealth molecule. Curr. Opin. Cell. Biol. 12:2000;581-586
21. Lin G., Stern R. Plasma hyaluronidase (Hyal-1) promotes tumor cell cycling. Cancer Lett. 163:2001;95-101
22. Lipponen P., Aaltomaa S., Tammi R., Tammi M., Agren U., Kosma V.M. High stromal hyaluronan level is associated with poor differentiation and metastasis in prostate cancer. Eur. J. Cancer. 37:2001;849-856
23. Liu D., Pearlman E., Diaconu E., Guo K., Mori H., Haqqi T., et al. Expression of hyaluronidase by tumor cells induces angiogenesis in vivo. Proc. Natl. Acad. Sci. USA. 93:1996;7832-7837
24. Lokeshwar V.B., Lokeshwar B.L., Pham H.T., Block N.L. Association of elevated levels of hyaluronidase, a matrix-degrading enzyme, with prostate cancer progression. Cancer Res. 56:1996;651-657
25. Maaser K., Wolf K., Klein C.E., Niggemann B., Zanker K.S., Brocker E.B., et al. Functional hierarchy of simultaneously expressed adhesion receptors: integrin alpha2beta1 but not CD44 mediates MV3 melanoma cell migration and matrix reorganization within three-dimensional hyaluronan- containing collagen matrices. Mol. Biol. Cell. 10:1999;3067-3079
26. Maunoury R. Establishment and characterization of 3 human cell lines derived from intracerebral metastatic tumors. C.R. Acad. Sci. Hebd. Seances Acad. Sci. D. 284:1977;991-994
27. Mio K., Stern R. Inhibitors of the hyaluronidases. Matrix Biol. 21:2002;31-37
28. Miyake H., Hara I., Okamoto I., Gohji K., Yamanaka K., Arakawa S., et al. Interaction between CD44 and hyaluronic acid regulates human prostate cancer development. J. Urol. 160:1998;1562-1566
29. Montcourrier P., Silver I., Farnoud R., Bird I., Rochefort H. Breast cancer cells have a high capacity to acidify extracellular milieu by a dual mechanism. Clin. Exp. Metastasis. 15:1997;382-392
30. Nara Y., Kato Y., Torii Y., Tsuji Y., Nakagaki S., Goto S., et al. Immunohistochemical localization of extracellular matrix components in human breast tumours with special reference to PG-M/versicanm. Histochem. J. 29:1997;21-30
31. Patel S., Turner P.R., Stubberfield C., Barry E., Rohlff C.R., Stamps A., et al. Hyaluronidase gene profiling and role of hyal-1 overexpression in an orthotopic model of prostate cancer. Int. J. Cancer. 97:2002;416-424
32. Ponta H., Sherman L., Herrlich P.A. CD44: from adhesion molecules to signalling regulators. Nat. Rev. Mol. Cell. Biol. 4:2003;33-45
33. Prestwich G.D., Marecak D.M., Marecek J.F., Vercruysse K.P., Ziebell M.R. Controlled chemical modification of hyaluronic acid: synthesis, applications, and biodegradation of hydrazide derivatives. J. Control. Release. 53:1998;93-103
34. Radotra B., McCormick D. Glioma invasion in vitro is mediated by CD44-hyaluronan interactions. J. Pathol. 181:1997;434-438
35. Ramamurthi A., Vesely I. Smooth muscle cell adhesion on crosslinked hyaluronan gels. J. Biomed. Mater. Res. 60:2002;195-205
36. Reissig J.L., Strominger J.L., Leloir L.F. A modified colorimetric method for the estimation of N-acetylamino sugars. J. Biol. Chem. 217:1955;959-966
37. Shuster S., Frost G.I., Csoka A.B., Formby B., Stern R. Hyaluronidase reduces human breast cancer xenografts in SCID mice. Int. J. Cancer. 102:2002;192-197
38. Tonello C., Zavan B., Cortivo R., Brun P., Panfilo S., Abatangelo G. In vitro reconstruction of human dermal equivalent enriched with endothelial cells. Biomaterials. 24:2003;1205-1211
39. Toole B.P., Wight T.N., Tammi M.I. Hyaluronan-cell interactions in cancer and vascular disease. J. Biol. Chem. 277:2002;4593-4596
40. Toole B.P. Hyaluronan promotes the malignant phenotype. Glycobiology. 12:2002;37R-42R
41. Trudel J., Massia S.P. Assessment of the cytotoxicity of photocrosslinked dextran and hyaluronan-based hydrogels to vascular smooth muscle cells. Biomaterials. 23:2002;3299-3307
42. Walch E.T., Albino A.P., Marchetti D. Correlation of overexpression of the low-affinity p75 neurotrophin receptor with augmented invasion and heparanase production in human malignant melanoma cells. Int. J. Cancer. 82:1999;112-120